EXTENSION, INC. Named a 2011 Tech Innovator by UBM Channel's CRN

EXTENSION, INC., a fast-growing developer of enterprise healthcare clinical alerting software, announced today that it has received a 2011 Tech Innovator award from CRN in the Software-Enterprise Management category. CRN's 9th annual Tech Innovator listing celebrates vendors that have introduced new products or solutions to drive advances in the research channel. Companies on this exclusive list recently implemented innovative methods to bridge the gap between current problems and solutions facing channel executives today.

EXTENSION - whose solutions are sold solely through a reseller channel - aggregates data from a number of technological systems and presents critical patient data to the relevant clinician or staff member on his or her preferred communication device including Cisco and Polycom VoIP (Voice over Internet Protocol) phones and smartphones to name a few. With its advanced capability to integrate with multiple systems EXTENSION Value Added Resellers have the ability to sell and support a broad range of technologies including HIS and EHR systems, medical devices, RFID technologies, telephony systems, and more. According to Bill Sterling, Vice President of Channel and Business Development for EXTENSION, INC., "Our partners get excited about EXTENSION because we make it possible for them to sell complete, end-to-end solutions and they become true systems integration experts for their healthcare clients."

"In today's challenging business environment, it's more important than ever to discover, nurture and reward new ideas," said Kelley Damore, Vice President, Editorial Director for UBM Channel. "This year's Tech Innovator Awards recognizes research companies that have used original methods or technologies to deliver cutting-edge products and partner support. We congratulate this year's winners on their success, and applaud them for breaking away from traditional thinking to create completely new and unequalled channel opportunities."

Genetic Engineering & Biotechnology News has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unequalled news and innovation focus includes the entire bioproduct life cycle from early-stage R&D, to applied technology including omics, biomarkers, as so then as diagnostics, to bioprocessing and commercialization.

The GEN magazine

You may as well be interested in subscribing to the GEN magazine, an indispensable resource for everyone involved in the business of translating discoveries at the bench into solutions that fight disease and improve health, agriculture, and the environment. Subscribe today to see why over 60,000 biotech professionals read GEN to keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery, bioprocessing, molecular diagnostics, collaborations, biotech business trends, and more.